Applied Aerospace & Defense Inc reports results for the quarter ended June 30 - Earnings Summary
Applied Aerospace & Defense Inc reports results for the quarter ended June 30 - Earnings Summary
Applied Aerospace & Defense Inc AADX.N reported a quarterly adjusted loss of $1.04 per share for the quarter ended June 30. The mean expectation of four analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from zero cents to 7 cents per share.
Revenue was $167.32 million; analysts expected $155.85 million.
Applied Aerospace & Defense Inc's reported EPS for the quarter was a loss of $1.04.
The company reported a quarterly loss of $153.97 million.
Applied Aerospace & Defense Inc shares had fallen by 9.6% this quarter.
FORECAST CHANGES
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the aerospace & defense peer group is "buy."
Wall Street's median 12-month price target for Applied Aerospace & Defense Inc is $24.00, about 14.2% above its last closing price of $20.59
This summary was machine generated from LSEG data August 12 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.03 | -1.04 | Missed |
Recent news on Applied Aerospace & Defense
See all newsBrief: Applied Aerospace & Defense Appoints Robert Wingfield As Chief Information Officer
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US RESEARCH ROUNDUP-Essex Property Trust, Qualys, Vulcan Materials
US RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte